This trial compares using a device to detect parathyroid glands during thyroid surgery and whether it improves patient outcomes.
- Thyroid Cancer
- Postoperative Hypoparathyroidism
- Thyroid Disease
3 Primary · 8 Secondary · Reporting Duration: Up to 6 months after total thyroidectomy
Awards & Highlights
2 Treatment Groups
NIRAF Detection Technology (-)
1 of 2
NIRAF Detection Technology (+)
1 of 2
60 Total Participants · 2 Treatment Groups
Primary Treatment: NIRAF Detection Technology (+) · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 99 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
To what extent has the patient population grown since the beginning of this medical experiment?
"Indeed, the information posted on clinicaltrials.gov reveals that this trial is looking for additional participants as of October 11th 2022. The initial post date was 5th of October and only 60 patients are required from a single site." - Anonymous Online Contributor
Are there any vacancies for participation in this experiment?
"The clinicaltrials.gov website confirms that this investigation is actively recruiting patients, with its first posting taking place on October 5th 2022 and the most recent update being made on October 11th of the same year." - Anonymous Online Contributor
Can those under the age of 40 participate in this research project?
"This clinical research project only accepts participants aged 18 to 99. For people below the age of majority, there are 30 separate trials and for those over 65 years old, 229 different studies have been identified." - Anonymous Online Contributor
Who is the ideal demographic for enrolling in this experiment?
"This clinical trial is seeking around sixty individuals aged 18 to 99 with thyroid adenoma. The ideal participants should have been subject to a total thyroidectomy, or had one previously and still possess an intact gland. Furthermore, all recruits must be eligible for completion of their prior neck exploration procedure." - Anonymous Online Contributor
What is the ultimate goal of this investigation?
"The primary purpose of the trial is to assess postoperative hypoparathyroidism/hypocalcemia within 5-14 days after total thyroidectomy. Secondary aims include evaluations on the number of nights spent in hospital for recovery, auto-transplanted parathyroid glands, and overall number of identified parathyroid glands (with nude eye + NIRAF in experimental group; with naked eye alone in control)." - Anonymous Online Contributor